A Texas mom shared heartwarming video of her daughter’s delight after her brother came to visit her in the hospital. Abby was ...

Primary endpoint met in R/R mNPM1 AML patients in pivotal Phase 2 portion of the AUGMENT-101 trial – – Robust remission rates in heavily pre-treated R/R mNPM1 AML population with nearly 50% overall ...

A highly sensitive bone marrow test could double survival rates for some groups of younger adults with acute myeloid leukemia ...

Princess Margaret Cancer Center at University Health Network-led researchers constructed a detailed single-cell atlas of ...

Long-term survival rates of some Acute Myeloid Leukemia patients could double with sensitive bone marrow test. ScienceDaily . Retrieved April 30, 2025 from www.sciencedaily.com / releases / 2025 ...

Breeze Hunter, a 22-year-old college student, struggled for months with a sinus infection she couldn’t shake. She was later ...

A phase 1 trial evaluating SENTI-202 demonstrated positive preliminary results in treating relapsed/refractory acute myeloid ...

Scientists have developed a new, ready-made way to fight acute myeloid leukemia and other blood cancers that looks promising.

A new bone marrow test can help doctors predict risk of leukemia relapse. The test might double survival rates by predicting ...

After Hunter became too weak to walk to classes, she underwent a blood test. When doctors received the results, they urged ...